The big sequencing platform news this week is Roche's announcement that they are ending their collaborations aimed at developing new sequencing technologies. A collaboration with DNA Electronics aimed to create an Ion Torrent-like system whereas a more ambitious effort with IBM aimed to create instruments based on "DNA transistors". As noted by Forbes' Matthew Herper in a thought-provoking piece, Illumina is sitting very high atop the sequencer market.
Wednesday, April 24, 2013
Thursday, April 04, 2013
I've been mulling this item ever since AGBT, but have struggled with the title. I don't want to sound like I have a grudge against 454 ( truth is I just got some good datasets off this technology), but I do believe that they are few papers away from being stampeded. Or perhaps not; perhaps the community is really wedded to this platform.